| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |